Safety, Pharmacokinetics, and Pharmacodynamics of Ruzasvir (MK-8408) in Participants With Hepatitis C Infection (MK-8408-003)
Clinical trial NCT02076100 · COMPLETED
Trial details
- NCT number
- NCT02076100
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-27
- Primary completion
- 2015-11-15
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.